221 related articles for article (PubMed ID: 29884408)
21. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
[TBL] [Abstract][Full Text] [Related]
22. KMT2 (MLL) family of methyltransferases in head and neck squamous cell carcinoma: A systematic review.
da Silva Santos ME; de Carvalho Abreu AK; Martins da Silva FW; Barros Ferreira E; Diniz Dos Reis PE; do Amaral Rabello Ramos D
Head Neck; 2024 Feb; 46(2):417-434. PubMed ID: 38102754
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma.
Morvan VL; Richard É; Cadars M; Fessart D; Broca-Brisson L; Auzanneau C; Pasquies A; Modesto A; Lusque A; Mathoulin-Pélissier S; Lansiaux A; Robert J
Br J Cancer; 2020 Sep; 123(5):772-784. PubMed ID: 32565541
[TBL] [Abstract][Full Text] [Related]
24. Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.
Li Y; Goldberg EM; Chen X; Xu X; McGuire JT; Leuzzi G; Karagiannis D; Tate T; Farhangdoost N; Horth C; Dai E; Li Z; Zhang Z; Izar B; Que J; Ciccia A; Majewski J; Yoon AJ; Ailles L; Mendelsohn CL; Lu C
Mol Cell; 2022 Oct; 82(20):3901-3918.e7. PubMed ID: 36206767
[TBL] [Abstract][Full Text] [Related]
25. Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies?
Zilberg C; Lee MW; Kraitsek S; Ashford B; Ranson M; Shannon K; Iyer NG; Ch'ng S; Low TH; Palme C; Clark J; Gupta R; Yu B
J Clin Pathol; 2020 Jan; 73(1):17-22. PubMed ID: 31300530
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
Ebnoether E; Muller L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
28. Cancer treatment of the future: inhibitors of histone methyltransferases.
Spannhoff A; Sippl W; Jung M
Int J Biochem Cell Biol; 2009 Jan; 41(1):4-11. PubMed ID: 18773966
[TBL] [Abstract][Full Text] [Related]
29. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.
Kostareli E; Hielscher T; Zucknick M; Baboci L; Wichmann G; Holzinger D; Mücke O; Pawlita M; Del Mistro A; Boscolo-Rizzo P; Da Mosto MC; Tirelli G; Plinkert P; Dietz A; Plass C; Weichenhan D; Hess J
Epigenetics; 2016; 11(1):61-73. PubMed ID: 26786582
[TBL] [Abstract][Full Text] [Related]
30. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW; Soulières D; Le Tourneau C; Dinis J; Licitra L; Ahn MJ; Soria A; Machiels JP; Mach N; Mehra R; Burtness B; Zhang P; Cheng J; Swaby RF; Harrington KJ;
Lancet; 2019 Jan; 393(10167):156-167. PubMed ID: 30509740
[TBL] [Abstract][Full Text] [Related]
31. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
[TBL] [Abstract][Full Text] [Related]
32. Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review).
Frassanito MA; Saltarella I; Vinella A; Muzio LL; Pannone G; Fumarulo R; Vacca A; Mariggiò MA
Oncol Rep; 2019 May; 41(5):2615-2624. PubMed ID: 30896830
[TBL] [Abstract][Full Text] [Related]
33. High tRNA Transferase NSUN2 Gene Expression is Associated with Poor Prognosis in Head and Neck Squamous Carcinoma.
Lu L; Zhu G; Zeng H; Xu Q; Holzmann K
Cancer Invest; 2018 Apr; 36(4):246-253. PubMed ID: 29775108
[TBL] [Abstract][Full Text] [Related]
34. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
35. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
[TBL] [Abstract][Full Text] [Related]
37. Ethanolic Extract of Ocimum sanctum Leaves Reduced Invasion and Matrix Metalloproteinase Activity of Head and Neck Cancer Cell Lines.
Utispan K; Niyomtham N; Yingyongnarongkul BE; Koontongkaew S
Asian Pac J Cancer Prev; 2020 Feb; 21(2):363-370. PubMed ID: 32102512
[TBL] [Abstract][Full Text] [Related]
38. Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma.
Rozek LS; Virani S; Bellile EL; Taylor JMG; Sartor MA; Zarins KR; Virani A; Cote C; Worden FP; Mark MEP; McLean SA; Duffy SA; Yoo GH; Saba NF; Shin DM; Kucuk O; Wolf GT
Nutr Cancer; 2019; 71(5):772-780. PubMed ID: 30862188
[TBL] [Abstract][Full Text] [Related]
39. Cancers and the NSD family of histone lysine methyltransferases.
Morishita M; di Luccio E
Biochim Biophys Acta; 2011 Dec; 1816(2):158-63. PubMed ID: 21664949
[TBL] [Abstract][Full Text] [Related]
40. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
